Hironori Takagi

Fukushima, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 40 publications

Abnormal phosphorylation of human LRH1 at Ser510 predicts poor prognosis and promotes cell viability in lung squamous cell carcinoma.

Abnormal phosphorylation of human LRH1 at Ser510 predicts poor prognosis and promotes cell viability in lung squamous cell carcinoma.

Journal: BMC cancer

Published: July 23, 2024

A case of discordant histology and expression of programmed death ligand 1 between primary tumor and brain metastases in adenosquamous carcinoma of the lung.

A case of discordant histology and expression of programmed death ligand 1 between primary tumor and brain metastases in adenosquamous carcinoma of the lung.

Journal: Thoracic cancer

Published: April 25, 2023

Clinical Features of Endocrine Disorders with Immune Checkpoint Inhibitor in Patients with Non-Small Cell Lung Cancer

Clinical Features of Endocrine Disorders with Immune Checkpoint Inhibitor in Patients with Non-Small Cell Lung Cancer

Journal: Gan to kagaku ryoho. Cancer & chemotherapy

Published: February 22, 2023

Wnt/β-Catenin Signaling and Resistance to Immune Checkpoint Inhibitors: From Non-Small-Cell Lung Cancer to Other Cancers.

Wnt/β-Catenin Signaling and Resistance to Immune Checkpoint Inhibitors: From Non-Small-Cell Lung Cancer to Other Cancers.

Journal: Biomedicines

Published: December 22, 2022

Resistance Mechanisms to Immune Checkpoint Inhibitor and Its Overcome with Focus on β-Catenin in Lung Cancer

Resistance Mechanisms to Immune Checkpoint Inhibitor and Its Overcome with Focus on β-Catenin in Lung Cancer

Journal: Gan to kagaku ryoho. Cancer & chemotherapy

Published: September 26, 2022

β-Catenin Expression in Non-Small Cell Lung Cancer and Therapeutic Effect of Immune Checkpoint Inhibitors

β-Catenin Expression in Non-Small Cell Lung Cancer and Therapeutic Effect of Immune Checkpoint Inhibitors

Journal: Gan to kagaku ryoho. Cancer & chemotherapy

Published: September 26, 2022

Large cell neuroendocrine carcinoma of the lung controlled for 4 years by a single administration of pembrolizumab: A case report.

Large cell neuroendocrine carcinoma of the lung controlled for 4 years by a single administration of pembrolizumab: A case report.

Journal: Thoracic cancer

Published: June 14, 2022

Thoracoscopic resection of posterior mediastinal paraganglioma: perioperative management and surgical tips.

Thoracoscopic resection of posterior mediastinal paraganglioma: perioperative management and surgical tips.

Journal: Journal of cardiothoracic surgery

Published: December 11, 2021

Ectopic adrenocorticotropic hormone-secreting carcinoid with solitary cryptococcosis in the lungs.

Ectopic adrenocorticotropic hormone-secreting carcinoid with solitary cryptococcosis in the lungs.

Journal: Cancer reports (Hoboken, N.J.)

Published: October 18, 2021

CTLA-4 Expression in Tumor-infiltrating Lymphocytes Is Irrelevant to PD-L1 Expression in NSCLC.

CTLA-4 Expression in Tumor-infiltrating Lymphocytes Is Irrelevant to PD-L1 Expression in NSCLC.

Journal: Anticancer research

Published: October 04, 2021

The clinical significance of tertiary lymphoid structure and its relationship with peripheral blood characteristics in patients with surgically resected non-small cell lung cancer: a single-center, retrospective study.

The clinical significance of tertiary lymphoid structure and its relationship with peripheral blood characteristics in patients with surgically resected non-small cell lung cancer: a single-center, retrospective study.

Journal: Cancer immunology, immunotherapy : CII

Published: May 19, 2021

CLDN15 is a novel diagnostic marker for malignant pleural mesothelioma.

CLDN15 is a novel diagnostic marker for malignant pleural mesothelioma.

Journal: Scientific reports

Published: March 17, 2021

Showing 1-12 of 40

Last Updated: 09/26/2026